The Basics of Symptom Management: Understanding, Assessment and Principles Dr. Leah Steinberg.

Slides:



Advertisements
Similar presentations
Pain Control in Hospice and Palliative Care
Advertisements

DYSPNEA IN PALLIATIVE CARE
Constipation and the Cancer Patient
Opioids and other drugs we use on palliative care
Spinal Cord Compression Pharmaceutical Issues Rebecca Mills Senior Clinical Pharmacist.
2 nd Cancer Pain Symposium Opiate Related Side Effects: Focus on Constipation Lydia Mis, PharmD, BCOP Clinical Oncology Pharmacist June 6, 2008 Duke University.
End of Life Curriculum Project-Lunchtime symposia for M1 & M2 Daniel McFarland NYCOM 2004.
Preparing for the Predictable Planning for common threats to comfort in the final days. Tamara Wells RN MN CNS Dr. M. Harlos Medical Director WRHA Palliative.
Constipation Definition *is adecrease in the frequency of fecal elimenation *hard / dry and somtime painfull stools *normal stool range from three time.
Primary treatment of constipation Explanation of symptoms and education Ensure adequate fluid intake (1500 mls) Adequate, but not excessive, fibre intake.
Paediatric Guidelines for the management of acute and post-operative pain. Paracetamol + NSAID + Strong Opioid 1. PARACETAMOL PLUS 2. NSAID ie Ibuprofen.
Paediatric Guidelines for the Management of Acute and Post-operative Pain. Paracetamol + NSAID + Strong Opioid 1. PARACETAMOL PLUS 2. NSAID ie Ibuprofen.
The Palliation of Dyspnea in Far Advanced Lung Cancer Dr. Anna Towers Division of Palliative Care McGill University.
{ Management of Advanced Breathlessness Dr Phil Wilkins, Norfolk and Norwich University Hospital and Priscilla Bacon Lodge, Norwich.
Palliative Management of Dyspnea
Pain Assessment and Management
“I can’t breathe”: The Challenge of Dyspnea
Non-pharmacological Treatment of Anxiety in the Primary Care Setting Presented by: Jonathan Betlinski, MD Date: 12/18/2014.
SpR topic: Constipation
Assessment and Management of Constipation
Constipation The University of Georgia Cooperative Extension Service.
Palliative Care: Shortness of Breath and Secretions Hong-Phuc Tran, M.D.
The EPEC-O Curriculum is produced by the EPEC TM Project with major funding provided by NCI, with supplemental funding provided by the Lance Armstrong.
What can we do to Palliate Dyspnea? Steve Dupuis DO Faith Hospice Associate Medical Director.
C C E E N N L L E E End-of-Life Nursing Education Consortium International Curriculum Symptom Management Symptom Management.
CARE OF DYING PATIENT Dorothy D. Sherwood, M.D. 6/11/2005.
Seminar in Palliative Care September 26 – October 02, 2010 Salzburg, Austria in Collaboration with.
The EPEC-O Curriculum is produced by the EPEC TM Project with major funding provided by NCI, with supplemental funding provided by the Lance Armstrong.
End of Life Care Education Case Scenario 3 End of Life Care Webinar MODULE 1.
Post Liverpool Care Pathway End of Life Conference Wednesday 14 May 2014 Dr Catherine J Dent Associate Specialist Macmillan Specialist Palliative Care.
Management of Constipation in Adults Stephen Aglubat, MD May 2012.
Managing Symptoms in Palliative Care. Aims  To gain an awareness of the most common symptoms in patients with life limiting diseases and why these occur.
End of Life Symptom Management Dec 3, 2014 Mudit Dabral Rosene Pirrello.
Common Symptoms at End of Life Stephanie Reynolds, MSN, NP, ACHPN Palliative Care, Jacobi Medical Center.

Palliative Care in Elderly Dr Asso Faraidoon Ali Amin MRCP(UK),DGM.
CONSTIPATION & IMPACTION By Faith-Insight Nursing Consultants.
Managing Symptoms at the End of Life When the Oral route Fails.
EPECEPECEPECEPEC GI Symptoms Module 10a The Education in Palliative and End-of-life Care program at Northwestern University Feinberg School of Medicine,
By Dr Marie Joseph MB BS FRCP Medical Director & Consultant in Palliative Medicine St Raphael’s Hospice, Surrey and Macmillan Consultant, Epsom & St Helier.
Bowel Trouble? By: Stephanie Adams. Interesting Facts Feeling Plugged up? ◦ It is normal for people to experience short periods of constipation. ◦ About.
Bradford & Airedale Palliative Care Managed Clinical Network Last few days of life Symptom Control.
EPECEPECEPECEPEC EPECEPECEPECEPEC Dyspnea Module 10c The Education in Palliative and End-of-life Care program at Northwestern University Feinberg School.
1. What is the most common cause of constipation? A.Pelvic floor dyssynergia B.Slow transit C.Functional D.Mechanical obstruction.
Geriatrics for Hospice and Palliative Care Providers Heather Herrington, MD Division of Geriatrics, Gerontology and Palliative Care University of Alabama.
Management of Constipation in Family Medicine Meera Kaur, PhD, RD, CDE Assistant Professor, Family Medicine University of Manitoba, Canada
Constipation: The Latest and Greatest Rosene Pirrello, RPh Solomon Liao, MD.
Pediatric Palliative Care C C E E N N L L E E Neurological Autonomic dysregulation Dystonias Restlessness/agitation Seizure.
Patient presenting with symptoms of constipation Identify causeIdentify cause. Consider disease, drugs, pregnancy, immobility, psychological problems Confirm.
Pain II: Cancer Pain Management Dr. Leah Steinberg.
Laxatives and Antidiarrheals
The Basics of Good Pain Control: Understanding and Assessment Dr. Leah Steinberg.
Palliative Care Anna DuPen ARNP, ACHPN Palliative Care Service UWMC.
Palliative Care: Non pain symptoms Elizabeth Whiteman, M.D.
TM The EPEC-O Project Education in Palliative and End-of-life Care - Oncology The EPEC TM -O Curriculum is produced by the EPEC TM Project with major funding.
TM The EPEC-O Project Education in Palliative and End-of-life Care - Oncology The EPEC TM -O Curriculum is produced by the EPEC TM Project with major funding.
Inadequately treated acute pain can lead to prolonged hospital stay, delayed recovery, psychological consequences, increased costs and the development.
What is Palliative Care? n Support and comfort for individuals and families living with chronic or life- threatening illnesses n Focuses on: –Relieving.
TM The EPEC-O Project Education in Palliative and End-of-life Care - Oncology The EPEC TM -O Curriculum is produced by the EPEC TM Project with major funding.
MINA KIM, PHARMD PAIN MANAGEMENT CLINICAL PHARMACIST Palliative Care.
Supportive and Palliative Care Pharmacology Toolkit for Non-Pain Symptom Management Shirley Brogley March 24, 2017.

Section II: Frequent Symptoms Associated with Imminent Death
Palliative Care in the Outpatient Setting: Pain Management
Dyspnea & cough.
Opioids and other drugs we use in palliative care
Rachel Williams Clinical Specialist Respiratory Physiotherapist
THE MODERN MANAGEMENT OF PAIN IN PALLIATIVE MEDICINE
How do I manage pain and agitation?
Management of Constipation in Adults
Presentation transcript:

The Basics of Symptom Management: Understanding, Assessment and Principles Dr. Leah Steinberg

Learning Objectives: List several good on-line resources; Review the model of pain and symptom management; Describe basic management of –Constipation, Delirium, Dyspnea Appreciate the principles of symptom management.

Cancer Care Ontario Guidelines Palliative care tools Symptom management tools

Objective 2: Review from yesterday Assess – rectal exam Treat underlying causes Treat symptoms –pharmacological and non-pharmacological Monitor Educate

Objective 3: Constipation Huge burden to patients Uncomfortable, AND Makes them stop using opioids

Constipation: Definition Infrequent, hard stools, difficult to pass Feeling of incomplete evacuation Not just infrequency

Multiple causes: we know these! Immobility Disease Neurologic abnormalities Metabolic abnormalities (hypercalcemia) Decreased intake Medications (OPIOIDS, anticholinergics) Weakness Physical surroundings

Again, to manage – follow the steps Assess – rectal exam Treat underlying causes Treat symptoms –pharmacological and non-pharmacological Monitor Educate

Management: Many products Know the classes of laxatives to use –Stimulant (senna) –Lubricant (mineral oil) –Osmotic (lactulose) –Opioid antagonist (methylnaltraxone) Usually don’t recommend: –Fibre or docusate Create a protocol for your practice

Set up regular dosing of laxatives: –Sennosides or bisacodyl: 2–4 tablets at bedtime to begin plus –Lactulose 30 mL at bedtime or –PEG 3350 powder 17 g once or twice daily Monitor daily. If no bowel movement by day 2: –Increase sennosides by 2 tablets (can be given in two doses) and increase lactulose or PEG 3350 to 30 mL twice daily If no bowel movement by day 3: –Perform rectal examination If stool in rectum: –Use phosphate enema or bisacodyl suppository If no stool in rectum and no contraindication: –Give oil enema followed by saline or tap water enema to clear Increase regular laxatives If problems continue: –Do flat-plate radiograph of abdomen –Switch stimulant laxative –Use regular enemas

Set up regular dosing of laxatives: –Sennosides or bisacodyl: 2–4 tablets at bedtime to begin plus –Lactulose 30 mL at bedtime or –PEG 3350 powder 17 g once or twice daily Monitor daily. If no bowel movement by day 2: –Increase sennosides by 2 tablets (can be given in two doses) and increase lactulose or PEG 3350 to 30 mL twice daily If no bowel movement by day 3: –Perform rectal examination If stool in rectum: –Use phosphate enema or bisacodyl suppository If no stool in rectum and no contraindication: –Give oil enema followed by saline or tap water enema to clear Increase regular laxatives If problems continue: –Do flat-plate radiograph of abdomen – Rule out Bowel obstruction –Switch stimulant laxative –Use regular enemas

Constipation Pearls! Prevent!!! If not, treat aggressively Myth: he’s not eating… Regular laxatives if regular opioids –Easier to decrease laxatives

Dyspnea: Frightening symptom Often linked with anxiety, fear Need lots of education and support for patient with severe dyspnea

Prevalence of dyspnea 50% - 70% of all cancer patients 60% of patients with NSCLC Worsens as disease progresses Prognostic indicator –When patients are dysnpeic at rest, prognosis is often in the range of weeks

Etiology Multifactorial: Dudgeon, Lertzman Dyspnea in the advanced cancer patient, JPSM 1998 Oct;16(4) Reviewed 100 pts to determine etiology of dyspnea; Average number of potential causes = 5

Etiology: many many causes From the Tumour itself; Compression Obstruction Carcinomatosis Other Card/Resp Dx COPD CHF Indirectly from tumour: Muscle weakness Anemia Thromboembolic disease Effusions: pleural, pericardial, peritoneal Infection

Again, to manage – follow the steps Assess: to diagnose –Tachypnea is not dyspnea Reverse when you can Treat the symptoms Monitor Educate

Treat underlying cause if possible: Antibiotics Drain effusion: +/- Tenchkoff catheter Radiotherapy Stents Transfusions

Non-pharmacological Education ++ Energy Conservation Breathing techniques Muscle strengthening Cool air/fan Positioning Relaxation exercises

Pharmacological Opioids are mainstay Methyltrimeprazine Anxiolytics Steroids Inhalers/diuretics Secretion management at EOL Trial of oxygen

What about respiration compromise? 11 studies looked for evidence of respiratory compromise – no clinically relevant compromise found Again, related to opioid naive

Opioid dosages Opioid-naïve patients, mild dyspnea –codeine 30 mg q 4 hr –morphine 2.5 mg q 4 hr Opioid-naïve patients, moderate - severe –morphine mg q 4 hr (or equivalent) –titrate % every 24 hrs –in COPD, start low and go slower

Opioid dosages Opioid tolerant patients –titrate baseline dose by %

Anxiolytics: if anxiety a component Lorazepam 1 – 2 mg sl q 8 hrs prn Clonazpam mg q 12 hr Midazolam mg s/c or iv q 20 mins prn

Steroids Dexamethasone 4 – 16 mg daily Can give in one dose in the morning, rather than qid

Dyspnea summary: Tachypnea is not dyspnea Reverse when you can Opioids are mainstay of medical therapy Use non-pharmacological measures when you can

Delirium Palliative care emergency! A delirious patient cannot express their symptoms; Distressing for patient and family Remember: –Hyperactive –Hypoactive

Patient’s remember their delirium 50% of patients remember the experience – It is frightening for them

To manage – follow the steps Assess: to diagnose –Don’t forget to do physical exam Reverse when you can Treat the symptoms Monitor Educate

Reverse when that is the goal Hydration Opioid rotation Bisphosponates Stop medications if possible

Non-pharmacologic measures: Quiet room Decrease stimulation Light Visible reminders of time and date Verbal orientation of patient

But most importantly: TREAT IT Don’t leave patient untreated while attempting to reverse: First line: –Haloperidol 0.5 mg bid plus breakthrough –Risperidone 0.5 mg bid plus breakthrough –Olanzipine 2.5 mg bid plus breakthrough –If severely agitated, we use Methyltrimeprazine

Delirium summary: Prevent it when possible –PCUs may use daily screening tool (CAM) Reverse when possible Treat always Counsel patient after, if needed

SUMMARY Many symptoms Don’t be overwhelmed Use the model Use the resources out there!

Opioids treat symptom of dyspnea Cochrane review Mechanism unclear Systemic naloxone increases dyspnea Opioid receptors in tracheobronchial tree and alveolar walls But, no clear role for nebulized though